Answer
Glofitamab (Columvi) must not be administered to patients with an active infection and should be temporarily withheld until the infection has resolved.
Sources for this answer
- Columvi 2.5 mg, 10 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 6Document updated
Sources checked